Table of Content

1 Influenza Drugs Market Overview
1.1 Influenza Drugs Product Overview
1.2 Influenza Drugs Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir Phosphate
1.2.3 Peramivir
1.2.4 Other Influenza Drugs
1.3 Global Influenza Drugs Market Size by Type
1.3.1 Global Influenza Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Influenza Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Influenza Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Influenza Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Influenza Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Influenza Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Influenza Drugs Sales Breakdown by Type (2018-2024)
2 Global Influenza Drugs Market Competition by Company
2.1 Global Top Players by Influenza Drugs Sales (2018-2024)
2.2 Global Top Players by Influenza Drugs Revenue (2018-2024)
2.3 Global Top Players by Influenza Drugs Price (2018-2024)
2.4 Global Top Manufacturers Influenza Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs Market Competitive Situation and Trends
2.5.1 Influenza Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs Market
2.8 Key Manufacturers Influenza Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs Status and Outlook by Region
3.1 Global Influenza Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Influenza Drugs Historic Market Size by Region
3.2.1 Global Influenza Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Influenza Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Influenza Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Influenza Drugs Forecasted Market Size by Region
3.3.1 Global Influenza Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Influenza Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Influenza Drugs by Application
4.1 Influenza Drugs Market Segment by Application
4.1.1 Adults
4.1.2 Chidren
4.2 Global Influenza Drugs Market Size by Application
4.2.1 Global Influenza Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Influenza Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Influenza Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Influenza Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Influenza Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Influenza Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Influenza Drugs Sales Breakdown by Application (2018-2024)
5 North America Influenza Drugs by Country
5.1 North America Influenza Drugs Historic Market Size by Country
5.1.1 North America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Influenza Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Influenza Drugs Sales in Value by Country (2018-2024)
5.2 North America Influenza Drugs Forecasted Market Size by Country
5.2.1 North America Influenza Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Influenza Drugs Sales in Value by Country (2024-2034)
6 Europe Influenza Drugs by Country
6.1 Europe Influenza Drugs Historic Market Size by Country
6.1.1 Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Influenza Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Influenza Drugs Sales in Value by Country (2018-2024)
6.2 Europe Influenza Drugs Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Influenza Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Influenza Drugs by Region
7.1 Asia-Pacific Influenza Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Influenza Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Influenza Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Influenza Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Influenza Drugs Sales in Value by Region (2024-2034)
8 Latin America Influenza Drugs by Country
8.1 Latin America Influenza Drugs Historic Market Size by Country
8.1.1 Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Influenza Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Influenza Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Influenza Drugs Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Influenza Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Influenza Drugs by Country
9.1 Middle East and Africa Influenza Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Influenza Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Influenza Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Influenza Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Influenza Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol-Myers Squibb]
10.1.1 Bristol-Myers Squibb] Company Information
10.1.2 Bristol-Myers Squibb] Introduction and Business Overview
10.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
10.1.5 Bristol-Myers Squibb] Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Influenza Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly Influenza Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche Influenza Drugs Products Offered
10.4.5 Roche Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GlaxoSmithKline Influenza Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Influenza Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Influenza Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 Sanofi Pasteur
10.8.1 Sanofi Pasteur Company Information
10.8.2 Sanofi Pasteur Introduction and Business Overview
10.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sanofi Pasteur Influenza Drugs Products Offered
10.8.5 Sanofi Pasteur Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Bayer Influenza Drugs Products Offered
10.9.5 Bayer Recent Development
10.10 Celgene
10.10.1 Celgene Company Information
10.10.2 Celgene Introduction and Business Overview
10.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Celgene Influenza Drugs Products Offered
10.10.5 Celgene Recent Development
10.11 Seqirus
10.11.1 Seqirus Company Information
10.11.2 Seqirus Introduction and Business Overview
10.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Seqirus Influenza Drugs Products Offered
10.11.5 Seqirus Recent Development
10.12 Protein Sciences Corporation
10.12.1 Protein Sciences Corporation Company Information
10.12.2 Protein Sciences Corporation Introduction and Business Overview
10.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Protein Sciences Corporation Influenza Drugs Products Offered
10.12.5 Protein Sciences Corporation Recent Development
10.13 Serum Institute of India
10.13.1 Serum Institute of India Company Information
10.13.2 Serum Institute of India Introduction and Business Overview
10.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Serum Institute of India Influenza Drugs Products Offered
10.13.5 Serum Institute of India Recent Development
10.14 Emergent Biosolutions
10.14.1 Emergent Biosolutions Company Information
10.14.2 Emergent Biosolutions Introduction and Business Overview
10.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Emergent Biosolutions Influenza Drugs Products Offered
10.14.5 Emergent Biosolutions Recent Development
10.15 BioCryst Pharmaceuticals
10.15.1 BioCryst Pharmaceuticals Company Information
10.15.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 BioCryst Pharmaceuticals Influenza Drugs Products Offered
10.15.5 BioCryst Pharmaceuticals Recent Development
10.16 Alvogen
10.16.1 Alvogen Company Information
10.16.2 Alvogen Introduction and Business Overview
10.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Alvogen Influenza Drugs Products Offered
10.16.5 Alvogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs Industrial Chain Analysis
11.4 Influenza Drugs Market Dynamics
11.4.1 Influenza Drugs Industry Trends
11.4.2 Influenza Drugs Market Drivers
11.4.3 Influenza Drugs Market Challenges
11.4.4 Influenza Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs Distributors
12.3 Influenza Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Zanamivir
Table 2. Major Company of Oseltamivir Phosphate
Table 3. Major Company of Peramivir
Table 4. Major Company of Other Influenza Drugs
Table 5. Global Influenza Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Influenza Drugs Sales by Type (2018-2024) & (K MT)
Table 7. Global Influenza Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Influenza Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Influenza Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Influenza Drugs Price by Type (2018-2024) & (USD/MT)
Table 11. Global Influenza Drugs Sales by Type (2024-2034) & (K MT)
Table 12. Global Influenza Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Influenza Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Influenza Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Influenza Drugs Price by Type (2024-2034) & (USD/MT)
Table 16. North America Influenza Drugs Sales by Type (2018-2024) & (K MT)
Table 17. North America Influenza Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Influenza Drugs Sales (K MT) by Type (2018-2024)
Table 19. Europe Influenza Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Influenza Drugs Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Influenza Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Influenza Drugs Sales (K MT) by Type (2018-2024)
Table 23. Latin America Influenza Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Influenza Drugs Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Influenza Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Influenza Drugs Sales by Company (2018-2024) & (K MT)
Table 27. Global Influenza Drugs Sales Share by Company (2018-2024)
Table 28. Global Influenza Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Influenza Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Influenza Drugs Price by Company (2018-2024) & (USD/MT)
Table 31. Global Influenza Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Influenza Drugs Market
Table 35. Key Manufacturers Influenza Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Influenza Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Influenza Drugs Sales by Region (2018-2024) & (K MT)
Table 39. Global Influenza Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Influenza Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Influenza Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Influenza Drugs Sales by Region (2024-2034) & (K MT)
Table 44. Global Influenza Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Influenza Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Influenza Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Influenza Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Influenza Drugs Sales by Application (2018-2024) & (K MT)
Table 50. Global Influenza Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Influenza Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Influenza Drugs Price by Application (2018-2024) & (USD/MT)
Table 54. Global Influenza Drugs Sales by Application (2024-2034) & (K MT)
Table 55. Global Influenza Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Influenza Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Influenza Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Influenza Drugs Price by Application (2024-2034) & (USD/MT)
Table 59. North America Influenza Drugs Sales by Application (2018-2024) (K MT)
Table 60. North America Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Influenza Drugs Sales by Application (2018-2024) (K MT)
Table 62. Europe Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Influenza Drugs Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Influenza Drugs Sales by Application (2018-2024) (K MT)
Table 66. Latin America Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Influenza Drugs Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Influenza Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Influenza Drugs Sales by Country (2018-2024) & (K MT)
Table 70. North America Influenza Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Influenza Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Influenza Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Influenza Drugs Sales by Country (2024-2034) & (K MT)
Table 74. North America Influenza Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Influenza Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Influenza Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Influenza Drugs Sales by Country (2018-2024) & (K MT)
Table 78. Europe Influenza Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Influenza Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Influenza Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Influenza Drugs Sales by Country (2024-2034) & (K MT)
Table 82. Europe Influenza Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Influenza Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Influenza Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Influenza Drugs Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Influenza Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Influenza Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Influenza Drugs Sales by Region (2024-2034) & (K MT)
Table 90. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Influenza Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Influenza Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Influenza Drugs Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Influenza Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Influenza Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Influenza Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Influenza Drugs Sales by Country (2024-2034) & (K MT)
Table 98. Latin America Influenza Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Influenza Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Influenza Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Influenza Drugs Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Influenza Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Influenza Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Influenza Drugs Sales by Country (2024-2034) & (K MT)
Table 106. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Influenza Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Influenza Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Bristol-Myers Squibb] Company Information
Table 110. Bristol-Myers Squibb] Introduction and Business Overview
Table 111. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. Bristol-Myers Squibb] Influenza Drugs Product
Table 113. Bristol-Myers Squibb] Recent Development
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Introduction and Business Overview
Table 116. AstraZeneca Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. AstraZeneca Influenza Drugs Product
Table 118. AstraZeneca Recent Development
Table 119. Eli Lilly Company Information
Table 120. Eli Lilly Introduction and Business Overview
Table 121. Eli Lilly Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Eli Lilly Influenza Drugs Product
Table 123. Eli Lilly Recent Development
Table 124. Roche Company Information
Table 125. Roche Introduction and Business Overview
Table 126. Roche Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Roche Influenza Drugs Product
Table 128. Roche Recent Development
Table 129. GlaxoSmithKline Company Information
Table 130. GlaxoSmithKline Introduction and Business Overview
Table 131. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. GlaxoSmithKline Influenza Drugs Product
Table 133. GlaxoSmithKline Recent Development
Table 134. Novartis Company Information
Table 135. Novartis Introduction and Business Overview
Table 136. Novartis Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Novartis Influenza Drugs Product
Table 138. Novartis Recent Development
Table 139. Pfizer Company Information
Table 140. Pfizer Introduction and Business Overview
Table 141. Pfizer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Pfizer Influenza Drugs Product
Table 143. Pfizer Recent Development
Table 144. Sanofi Pasteur Company Information
Table 145. Sanofi Pasteur Introduction and Business Overview
Table 146. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Sanofi Pasteur Influenza Drugs Product
Table 148. Sanofi Pasteur Recent Development
Table 149. Bayer Company Information
Table 150. Bayer Introduction and Business Overview
Table 151. Bayer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Bayer Influenza Drugs Product
Table 153. Bayer Recent Development
Table 154. Celgene Company Information
Table 155. Celgene Introduction and Business Overview
Table 156. Celgene Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 157. Celgene Influenza Drugs Product
Table 158. Celgene Recent Development
Table 159. Seqirus Company Information
Table 160. Seqirus Introduction and Business Overview
Table 161. Seqirus Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 162. Seqirus Influenza Drugs Product
Table 163. Seqirus Recent Development
Table 164. Protein Sciences Corporation Company Information
Table 165. Protein Sciences Corporation Introduction and Business Overview
Table 166. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 167. Protein Sciences Corporation Influenza Drugs Product
Table 168. Protein Sciences Corporation Recent Development
Table 169. Serum Institute of India Company Information
Table 170. Serum Institute of India Introduction and Business Overview
Table 171. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 172. Serum Institute of India Influenza Drugs Product
Table 173. Serum Institute of India Recent Development
Table 174. Emergent Biosolutions Company Information
Table 175. Emergent Biosolutions Introduction and Business Overview
Table 176. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 177. Emergent Biosolutions Influenza Drugs Product
Table 178. Emergent Biosolutions Recent Development
Table 179. BioCryst Pharmaceuticals Company Information
Table 180. BioCryst Pharmaceuticals Introduction and Business Overview
Table 181. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 182. BioCryst Pharmaceuticals Influenza Drugs Product
Table 183. BioCryst Pharmaceuticals Recent Development
Table 184. Alvogen Company Information
Table 185. Alvogen Introduction and Business Overview
Table 186. Alvogen Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 187. Alvogen Influenza Drugs Product
Table 188. Alvogen Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Influenza Drugs Market Trends
Table 192. Influenza Drugs Market Drivers
Table 193. Influenza Drugs Market Challenges
Table 194. Influenza Drugs Market Restraints
Table 195. Influenza Drugs Distributors List
Table 196. Influenza Drugs Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Influenza Drugs Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Zanamivir
Figure 6. Global Zanamivir Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Oseltamivir Phosphate
Figure 8. Global Oseltamivir Phosphate Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Peramivir
Figure 10. Global Peramivir Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Other Influenza Drugs
Figure 12. Global Other Influenza Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Global Influenza Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Influenza Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Influenza Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Influenza Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Influenza Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Influenza Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Influenza Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Influenza Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Influenza Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Influenza Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs Revenue in 2022
Figure 27. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Adults
Figure 29. Global Adults Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Chidren
Figure 31. Global Chidren Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Global Influenza Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Influenza Drugs Sales Market Share by Application in 2022 & 2034
Figure 34. North America Influenza Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Influenza Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Influenza Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Influenza Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Influenza Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Influenza Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Influenza Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Influenza Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Influenza Drugs Manufacturing Cost Structure
Figure 45. Influenza Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed